XT
CNSP icon

XTX Topco’s CNS Pharmaceuticals CNSP Stock Holding History

XTX Topco’s Portfolio CNSP Stock Details CNSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-492
Closed -$35.5K – 2502
2024
Q4 		$35.5K Buy
+492
New +$35K ﹤0.01% 1953
2024
Q2 		– Sell
-1
Closed -$6.78K – 1955
2024
Q1 		$6.78K Buy
+1
New +$14.5K ﹤0.01% 1695
2023
Q4 		– Hold
0
– – – 1407

Other funds holding CNSP

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
GSC
Ground Swell Capital Folly Beach, South Carolina $50.7M AUM 30.19% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
BC
Barrett & Company Providence, Rhode Island $357M AUM 22.45% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

XTX Topco's CNSP Position: Q1 2025 in Review

XTX Topco sold out of CNS Pharmaceuticals (CNSP) in Q1 2025, closing a stake of 492 shares — an estimated $35.5K sold.

XTX Topco first reported a position in CNSP in Q1 2024 and held it in 2 quarters. The position peaked at $35.5K in Q4 2024. 7 funds tracked by Wall St. Rank hold CNSP as of Q1 2025.

  • XTX Topco reported no remaining CNS Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • XTX Topco sold 492 CNS Pharmaceuticals shares in Q1 2025, an estimated $35.5K.
  • XTX Topco first reported a position in CNS Pharmaceuticals in Q1 2024 and held it in 2 quarters.
  • XTX Topco's CNS Pharmaceuticals position peaked at $35.5K in Q4 2024.
  • 7 funds tracked by Wall St. Rank held CNS Pharmaceuticals as of Q1 2025.

Based on XTX Topco's 13F filing for Q1 2025, filed 8 May 2025.